Ultrastructural effects of PCMS on mycelial-yeast transition in Histoplasma capsulatum. 1991

G Borgia, and A Tallarino, and J Crowell, and A Lambiase, and L Reynaud, and S Cicciarello, and S Nappa, and G Nasti, and G di Gennaro, and M Sardo
Clinica delle Malattie Infettive, II Facoltà di Medicina e Chirurgia, Università di Napoli, Italy.

The Yeast phase of Histoplasma capsulatum has stringent growth requirements. Transition from mycelium to yeast takes place only in the presence of cysteine and can be blocked by the -SH groups inhibitor p-chloromercury-phenylsulfonic acid (PCMS). Ultrastructural studies show lysis and degeneration of PCMS treated mycelium grown at 37 degrees C for 24 hours. Only 50% of PCMS treated mycelium appear degenerate when grown at 34 degrees C for 24 hours. The remaining cells have normal morphology with only slight changes in the cell wall structure. The effect of PCMS is permanent and hereditary. Mice injected with PCMS treated mycelium do not develop disease and are resistant to virulent strains of H. capsulatum when challenged.

UI MeSH Term Description Entries
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002731 4-Chloromercuribenzenesulfonate A cytotoxic sulfhydryl reagent that inhibits several subcellular metabolic systems and is used as a tool in cellular physiology. Chloromercuriphenylsulfonate,PCMBS,Chloromercuribenzene-p-sulphonic Acid,Chloromercuribenzenesulfonate,PCMPS,p-Chloromercuriphenylsulphonate,4 Chloromercuribenzenesulfonate,Acid, Chloromercuribenzene-p-sulphonic,Chloromercuribenzene p sulphonic Acid,p Chloromercuriphenylsulphonate
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D006658 Histoplasma A mitosporic Onygenales fungal genus causing HISTOPLASMOSIS in humans and animals. Its single species is Histoplasma capsulatum which has two varieties: H. capsulatum var. capsulatum and H. capsulatum var. duboisii. Its teleomorph is AJELLOMYCES capsulatus. Ajellomyces capsulatus,Cryptococcus capsulatus,Emmonsiella capsulata,Histoplasma capsulatum,Histoplasmas
D013439 Sulfhydryl Reagents Chemical agents that react with SH groups. This is a chemically diverse group that is used for a variety of purposes. Among these are enzyme inhibition, enzyme reactivation or protection, and labelling. SH-Reagents,Sulfhydryl Compound Antagonists,Sulfhydryl Compound Inhibitors,Thiol Reagents,Sulfhydryl Compounds Antagonists,Sulfhydryl Compounds Inhibitors,Antagonists, Sulfhydryl Compound,Antagonists, Sulfhydryl Compounds,Compound Antagonists, Sulfhydryl,Compound Inhibitors, Sulfhydryl,Inhibitors, Sulfhydryl Compound,Inhibitors, Sulfhydryl Compounds,Reagents, Sulfhydryl,Reagents, Thiol,SH Reagents

Related Publications

G Borgia, and A Tallarino, and J Crowell, and A Lambiase, and L Reynaud, and S Cicciarello, and S Nappa, and G Nasti, and G di Gennaro, and M Sardo
January 1986, Science (New York, N.Y.),
G Borgia, and A Tallarino, and J Crowell, and A Lambiase, and L Reynaud, and S Cicciarello, and S Nappa, and G Nasti, and G di Gennaro, and M Sardo
November 1973, Sabouraudia,
G Borgia, and A Tallarino, and J Crowell, and A Lambiase, and L Reynaud, and S Cicciarello, and S Nappa, and G Nasti, and G di Gennaro, and M Sardo
May 1979, Journal of bacteriology,
G Borgia, and A Tallarino, and J Crowell, and A Lambiase, and L Reynaud, and S Cicciarello, and S Nappa, and G Nasti, and G di Gennaro, and M Sardo
March 1976, Sabouraudia,
G Borgia, and A Tallarino, and J Crowell, and A Lambiase, and L Reynaud, and S Cicciarello, and S Nappa, and G Nasti, and G di Gennaro, and M Sardo
December 1980, Sabouraudia,
G Borgia, and A Tallarino, and J Crowell, and A Lambiase, and L Reynaud, and S Cicciarello, and S Nappa, and G Nasti, and G di Gennaro, and M Sardo
June 1972, Mycopathologia et mycologia applicata,
G Borgia, and A Tallarino, and J Crowell, and A Lambiase, and L Reynaud, and S Cicciarello, and S Nappa, and G Nasti, and G di Gennaro, and M Sardo
August 1957, Journal of bacteriology,
G Borgia, and A Tallarino, and J Crowell, and A Lambiase, and L Reynaud, and S Cicciarello, and S Nappa, and G Nasti, and G di Gennaro, and M Sardo
June 1955, Journal of bacteriology,
G Borgia, and A Tallarino, and J Crowell, and A Lambiase, and L Reynaud, and S Cicciarello, and S Nappa, and G Nasti, and G di Gennaro, and M Sardo
October 1974, Mycopathologia et mycologia applicata,
G Borgia, and A Tallarino, and J Crowell, and A Lambiase, and L Reynaud, and S Cicciarello, and S Nappa, and G Nasti, and G di Gennaro, and M Sardo
May 1976, Nature,
Copied contents to your clipboard!